Table I.

Clinical characteristics of the patients at the time of initiation of anakinra therapy

PatientAgeSexDisease
 durationFlare
 durationFever/
 rashActive
 arthritisOral
 prednisonei.v.
 solumedrolMTXPrevious
 anti-TNFFollow-up
momo(frequency)mo
Sys3317F366YesYesYesYes (q. 4 wk)YesYes12
Sys479M2912YesYesYesYes (q. 2 wk)NoNo12
Sys564F2313YesYesYesYes (q. 1 wk)YesNo8
Sys212F125125YesYesYesYes (q. 4 wk)YesYes6
Sys126F3510YesNoYesYes (q. 4 wk)YesYes6
Sys154F3030NoYesYesYes (q. 4 wk)NoYes6
Sys216F405YesYesYesYes (q. 2 wk)YesNo4
Sys384M3818YesYesYesNoYesNo4
Sys2514F14430NoYesYesNoYesNo2